Avenue Therapeutics Inc. (NASDAQ: ATXI) Stock Information | RedChip

Avenue Therapeutics Inc. (NASDAQ: ATXI) Listen to this Section


$2.57
+0.1150 ( +4.68% ) 17.0K

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.

Market Data


Open


$2.57

Previous close


$2.46

Volume


17.0K

Market cap


$3.70M

Day range


$2.43 - $2.60

52 week range


$2.25 - $77.25

Insider Ownership Transactions

Total Amount Purchased: -2,011,918.00 | $ -5,170,629.26

Date Type Amount Purchased Purchaser
2024-04-17 Sale -413507.00 Fortress Biotech, Inc.
2024-01-03 Sale -2101496.00 Fortress Biotech, Inc.
2023-12-13 Sale -264000.00 Davidow Robert L
2023-09-12 Buy 418410.00 Fortress Biotech, Inc.
2023-09-12 Buy 348675.00 ROSENWALD LINDSAY A MD

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 16 Aug 09, 2024
10-q Quarterly Reports 54 Aug 09, 2024
8-k 8K-related 15 Jun 26, 2024
8-k 8K-related 14 May 23, 2024
10-q Quarterly Reports 56 May 15, 2024
8-k 8K-related 16 May 15, 2024
8-k 8K-related 16 May 13, 2024
def Proxies and info statements 5 May 06, 2024
8-k 8K-related 20 May 01, 2024
8-k 8K-related 17 Apr 26, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.